Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When you start tirzepatide—a dual GLP-1 and GIP receptor agonist—your healthcare provider begins you on a low dose to minimize side effects while your body adapts to the medication. The starting dose is carefully chosen based on your individual health profile, weight, and metabolic factors, not a one-size-fits-all approach. Understanding how this process works helps you prepare for your weight loss journey and set realistic expectations for results.
Standard Tirzepatide Starting Dosage
Tirzepatide treatment typically begins at 2.5 milligrams once weekly by subcutaneous injection. This introductory dose is intentionally modest to allow your body to acclimate to the medication's effects on appetite, blood sugar, and metabolism. Starting low reduces the risk of nausea, vomiting, and other gastrointestinal side effects that can occur during the first few weeks of treatment.
Your healthcare provider monitors your response during this initial phase, usually for 4 weeks before considering a dose increase. If you tolerate the 2.5 mg dose well and your weight loss and metabolic markers are progressing, your dose may advance to the next level. The goal is finding your optimal therapeutic dose—the amount that delivers maximum benefit with manageable side effects specific to your body.
How Your Dose May Progress Over Time
After the first month, tirzepatide doses typically increase in 2.5 mg increments: from 2.5 mg to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg weekly. Each step upward usually occurs every 4 weeks if you continue to tolerate the medication and your provider determines progression is appropriate for your goals. This gradual titration schedule—called stepped dosing—balances efficacy with tolerability, reducing the chance you'll abandon treatment due to intolerable side effects.
Not all patients reach the highest dose, and that's perfectly normal. Some people achieve their weight loss targets and maintain metabolic improvements at 5 mg or 7.5 mg weekly. Your dose journey is individual and depends on your weight loss response, side effect profile, and clinical markers like blood sugar control. PlexusDx emphasizes this personalization: your dose may need to go up, but your price won't—you pay a flat rate regardless of your current or future dosage level.
Factors That Influence Your Starting Dose
Your healthcare provider considers multiple factors when selecting your tirzepatide starting dose, including your current weight, body mass index (BMI), kidney and liver function, blood sugar status, and prior experience with GLP-1 medications. Patients with type 2 diabetes may begin at the same 2.5 mg dose as those seeking weight loss, though clinical intent influences monitoring frequency and dose escalation timelines. Genetic variations in how your body processes and responds to peptide therapies can also play a role in dose optimization.
PlexusDx offers the Precision Peptide Genetic Test—a 49-peptide, 14-pathway analysis—to identify genetic markers like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 that influence your individual response to tirzepatide. Understanding these insights allows your provider to personalize your initial dose selection and predict your likely dose progression, potentially accelerating you toward your therapeutic target with fewer trial-and-error adjustments.
PlexusDx Tirzepatide Pricing and Dosing Support
PlexusDx delivers compounded tirzepatide injections from licensed 503A compounding pharmacies starting at $249 per month. This flat-rate pricing applies whether you're taking 2.5 mg weekly or 15 mg weekly—your dose may increase, but your cost remains stable. PlexusDx serves all 50 states without requiring insurance, and tirzepatide is HSA/FSA eligible, making precision weight loss therapy accessible to more patients.
Your PlexusDx provider and clinical team guide you through each dose transition, monitor your metabolic markers and weight loss progress, and adjust your protocol based on real-world outcomes. If you want genetic insight into your peptide pathway predispositions, the Precision Peptide Genetic Test ($99 add-on after your first treatment month) provides 150+ actionable genetic insights that inform dose strategy and medication selection, helping you reach your goals faster and with greater confidence.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of tirzepatide?
Most patients begin tirzepatide at 2.5 mg injected once weekly under the skin. This low starting dose minimizes side effects while your body adapts. Your provider reassesses after 4 weeks and may increase your dose if you're tolerating it well.
How quickly does tirzepatide dose increase?
Tirzepatide doses typically increase by 2.5 mg increments every 4 weeks, moving from 2.5 mg up to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg weekly. Your provider controls the pace based on your weight loss, metabolic response, and side effect tolerance.
Does starting dose affect how much weight I'll lose?
Clinical trials show that tirzepatide produces dose-dependent weight loss: higher doses typically deliver greater reductions. However, individual response varies significantly, and some patients achieve their goals at moderate doses. Your provider helps identify the dose that maximizes your personal benefit.
Will I pay more if my dose increases with PlexusDx?
No. PlexusDx tirzepatide injection costs a flat $249 per month regardless of your current or future dose level. Your dose may increase, but your price won't, making long-term treatment predictable and affordable.
Can genetic testing help determine my ideal starting dose?
Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 49 peptides across 14 pathways, including key tirzepatide-response variants like GLP1R and GIPR. These insights help your provider predict your likely dose progression and personalize your starting strategy from day one.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Ozempic Dosing: What is Average Dose of Ozempic and Your Path to Wellness
When Should I Start Losing Weight on Zepbound?